NEUROSCI LETT 润色咨询

NEUROSCIENCE LETTERS

出版年份：1975 年文章数：14280 投稿命中率： 开通期刊会员，数据随心看

出版周期：Weekly 自引率：3.6% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=577521, encodeId=11de5e75218e, content=只有细胞实验不接收吗？<span class="quote">Super Wang 2018-12-14 发表::<br>接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span><span class="quote">Super Wang 2018-12-14 00:00:00 发表:<br>挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span>, beContent=Super Wang 2018-12-14 发表:: 接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/09/c7ee18c19a20424fa380fd58a595bc4a.jpg, createdBy=5ea55077990, createdName=纯熙, createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096192, encodeId=9598109619262, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096191, encodeId=f29710961916a, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910569, encodeId=5b019105697d, content=接受meta分析吗？大神们请教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfbf1562612, createdName=zhangkaili-2009, createdTime=Thu Dec 24 10:00:35 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570172, encodeId=37565e0172e2, content=投2个多月了，还是with editor，谁知道怎磨回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL7QWEibBRUvZpBhSPzZ4XmuyiacY6Upo6KuRic0GCSNrnvAbibcQM5o0PHLyHgLqGSDkTME7IiahWGUew/132, createdBy=af0d1725742, createdName=Dennisyan, createdTime=Sun Apr 28 18:41:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893988, encodeId=11778939889b, content=什么方向易中，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b821642529, createdName=杏林阳光, createdTime=Fri Oct 23 18:58:30 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891979, encodeId=3b908919e98b, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：+维生素b, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd75425765, createdName=ms3000001625445038, createdTime=Wed Oct 14 12:18:43 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884562, encodeId=361b8845620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：分享经验：6月底投稿，1个月审回，大修，按照审稿意见补完后小修一次，9月初被接收。杂志语言要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f235196076, createdName=14728afem42暂无昵称, createdTime=Fri Sep 11 16:12:56 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578003, encodeId=20795e80035d, content=请问，接受case report<span class="quote">150****9157暂无昵称 2019-10-08 发表::<br>只有细胞实验不接收吗？</span><span class="quote">150****9157暂无昵称 2019-10-08 00:00:00 发表:<br>只有细胞实验不接收吗？</span>, beContent=150****9157暂无昵称 2019-10-08 发表:: 只有细胞实验不接收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581581, encodeId=06b658158184, content=接受临床文章不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=)]
    2019-10-08 纯熙

    只有细胞实验不接收吗？Super Wang 2018-12-14 发表::
    接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！    Super Wang 2018-12-14 00:00:00 发表:
    挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！

    Super Wang 2018-12-14 发表:: 接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=577521, encodeId=11de5e75218e, content=只有细胞实验不接收吗？<span class="quote">Super Wang 2018-12-14 发表::<br>接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span><span class="quote">Super Wang 2018-12-14 00:00:00 发表:<br>挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span>, beContent=Super Wang 2018-12-14 发表:: 接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/09/c7ee18c19a20424fa380fd58a595bc4a.jpg, createdBy=5ea55077990, createdName=纯熙, createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096192, encodeId=9598109619262, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096191, encodeId=f29710961916a, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910569, encodeId=5b019105697d, content=接受meta分析吗？大神们请教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfbf1562612, createdName=zhangkaili-2009, createdTime=Thu Dec 24 10:00:35 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570172, encodeId=37565e0172e2, content=投2个多月了，还是with editor，谁知道怎磨回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL7QWEibBRUvZpBhSPzZ4XmuyiacY6Upo6KuRic0GCSNrnvAbibcQM5o0PHLyHgLqGSDkTME7IiahWGUew/132, createdBy=af0d1725742, createdName=Dennisyan, createdTime=Sun Apr 28 18:41:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893988, encodeId=11778939889b, content=什么方向易中，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b821642529, createdName=杏林阳光, createdTime=Fri Oct 23 18:58:30 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891979, encodeId=3b908919e98b, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：+维生素b, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd75425765, createdName=ms3000001625445038, createdTime=Wed Oct 14 12:18:43 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884562, encodeId=361b8845620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：分享经验：6月底投稿，1个月审回，大修，按照审稿意见补完后小修一次，9月初被接收。杂志语言要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f235196076, createdName=14728afem42暂无昵称, createdTime=Fri Sep 11 16:12:56 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578003, encodeId=20795e80035d, content=请问，接受case report<span class="quote">150****9157暂无昵称 2019-10-08 发表::<br>只有细胞实验不接收吗？</span><span class="quote">150****9157暂无昵称 2019-10-08 00:00:00 发表:<br>只有细胞实验不接收吗？</span>, beContent=150****9157暂无昵称 2019-10-08 发表:: 只有细胞实验不接收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581581, encodeId=06b658158184, content=接受临床文章不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=)]
    2021-12-27 桑晒麦拉

    引言一般分几段？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=577521, encodeId=11de5e75218e, content=只有细胞实验不接收吗？<span class="quote">Super Wang 2018-12-14 发表::<br>接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span><span class="quote">Super Wang 2018-12-14 00:00:00 发表:<br>挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span>, beContent=Super Wang 2018-12-14 发表:: 接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/09/c7ee18c19a20424fa380fd58a595bc4a.jpg, createdBy=5ea55077990, createdName=纯熙, createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096192, encodeId=9598109619262, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096191, encodeId=f29710961916a, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910569, encodeId=5b019105697d, content=接受meta分析吗？大神们请教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfbf1562612, createdName=zhangkaili-2009, createdTime=Thu Dec 24 10:00:35 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570172, encodeId=37565e0172e2, content=投2个多月了，还是with editor，谁知道怎磨回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL7QWEibBRUvZpBhSPzZ4XmuyiacY6Upo6KuRic0GCSNrnvAbibcQM5o0PHLyHgLqGSDkTME7IiahWGUew/132, createdBy=af0d1725742, createdName=Dennisyan, createdTime=Sun Apr 28 18:41:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893988, encodeId=11778939889b, content=什么方向易中，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b821642529, createdName=杏林阳光, createdTime=Fri Oct 23 18:58:30 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891979, encodeId=3b908919e98b, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：+维生素b, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd75425765, createdName=ms3000001625445038, createdTime=Wed Oct 14 12:18:43 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884562, encodeId=361b8845620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：分享经验：6月底投稿，1个月审回，大修，按照审稿意见补完后小修一次，9月初被接收。杂志语言要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f235196076, createdName=14728afem42暂无昵称, createdTime=Fri Sep 11 16:12:56 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578003, encodeId=20795e80035d, content=请问，接受case report<span class="quote">150****9157暂无昵称 2019-10-08 发表::<br>只有细胞实验不接收吗？</span><span class="quote">150****9157暂无昵称 2019-10-08 00:00:00 发表:<br>只有细胞实验不接收吗？</span>, beContent=150****9157暂无昵称 2019-10-08 发表:: 只有细胞实验不接收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581581, encodeId=06b658158184, content=接受临床文章不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    引言怎么写？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=577521, encodeId=11de5e75218e, content=只有细胞实验不接收吗？<span class="quote">Super Wang 2018-12-14 发表::<br>接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span><span class="quote">Super Wang 2018-12-14 00:00:00 发表:<br>挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span>, beContent=Super Wang 2018-12-14 发表:: 接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/09/c7ee18c19a20424fa380fd58a595bc4a.jpg, createdBy=5ea55077990, createdName=纯熙, createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096192, encodeId=9598109619262, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096191, encodeId=f29710961916a, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910569, encodeId=5b019105697d, content=接受meta分析吗？大神们请教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfbf1562612, createdName=zhangkaili-2009, createdTime=Thu Dec 24 10:00:35 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570172, encodeId=37565e0172e2, content=投2个多月了，还是with editor，谁知道怎磨回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL7QWEibBRUvZpBhSPzZ4XmuyiacY6Upo6KuRic0GCSNrnvAbibcQM5o0PHLyHgLqGSDkTME7IiahWGUew/132, createdBy=af0d1725742, createdName=Dennisyan, createdTime=Sun Apr 28 18:41:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893988, encodeId=11778939889b, content=什么方向易中，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b821642529, createdName=杏林阳光, createdTime=Fri Oct 23 18:58:30 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891979, encodeId=3b908919e98b, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：+维生素b, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd75425765, createdName=ms3000001625445038, createdTime=Wed Oct 14 12:18:43 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884562, encodeId=361b8845620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：分享经验：6月底投稿，1个月审回，大修，按照审稿意见补完后小修一次，9月初被接收。杂志语言要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f235196076, createdName=14728afem42暂无昵称, createdTime=Fri Sep 11 16:12:56 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578003, encodeId=20795e80035d, content=请问，接受case report<span class="quote">150****9157暂无昵称 2019-10-08 发表::<br>只有细胞实验不接收吗？</span><span class="quote">150****9157暂无昵称 2019-10-08 00:00:00 发表:<br>只有细胞实验不接收吗？</span>, beContent=150****9157暂无昵称 2019-10-08 发表:: 只有细胞实验不接收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581581, encodeId=06b658158184, content=接受临床文章不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=)]
    2020-12-24 zhangkaili-2009

    接受meta分析吗？大神们请教！

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=577521, encodeId=11de5e75218e, content=只有细胞实验不接收吗？<span class="quote">Super Wang 2018-12-14 发表::<br>接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span><span class="quote">Super Wang 2018-12-14 00:00:00 发表:<br>挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span>, beContent=Super Wang 2018-12-14 发表:: 接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/09/c7ee18c19a20424fa380fd58a595bc4a.jpg, createdBy=5ea55077990, createdName=纯熙, createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096192, encodeId=9598109619262, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096191, encodeId=f29710961916a, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910569, encodeId=5b019105697d, content=接受meta分析吗？大神们请教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfbf1562612, createdName=zhangkaili-2009, createdTime=Thu Dec 24 10:00:35 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570172, encodeId=37565e0172e2, content=投2个多月了，还是with editor，谁知道怎磨回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL7QWEibBRUvZpBhSPzZ4XmuyiacY6Upo6KuRic0GCSNrnvAbibcQM5o0PHLyHgLqGSDkTME7IiahWGUew/132, createdBy=af0d1725742, createdName=Dennisyan, createdTime=Sun Apr 28 18:41:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893988, encodeId=11778939889b, content=什么方向易中，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b821642529, createdName=杏林阳光, createdTime=Fri Oct 23 18:58:30 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891979, encodeId=3b908919e98b, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：+维生素b, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd75425765, createdName=ms3000001625445038, createdTime=Wed Oct 14 12:18:43 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884562, encodeId=361b8845620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：分享经验：6月底投稿，1个月审回，大修，按照审稿意见补完后小修一次，9月初被接收。杂志语言要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f235196076, createdName=14728afem42暂无昵称, createdTime=Fri Sep 11 16:12:56 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578003, encodeId=20795e80035d, content=请问，接受case report<span class="quote">150****9157暂无昵称 2019-10-08 发表::<br>只有细胞实验不接收吗？</span><span class="quote">150****9157暂无昵称 2019-10-08 00:00:00 发表:<br>只有细胞实验不接收吗？</span>, beContent=150****9157暂无昵称 2019-10-08 发表:: 只有细胞实验不接收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581581, encodeId=06b658158184, content=接受临床文章不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=)]
    2019-04-28 Dennisyan

    投2个多月了，还是with editor，谁知道怎磨回事？

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=577521, encodeId=11de5e75218e, content=只有细胞实验不接收吗？<span class="quote">Super Wang 2018-12-14 发表::<br>接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span><span class="quote">Super Wang 2018-12-14 00:00:00 发表:<br>挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span>, beContent=Super Wang 2018-12-14 发表:: 接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/09/c7ee18c19a20424fa380fd58a595bc4a.jpg, createdBy=5ea55077990, createdName=纯熙, createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096192, encodeId=9598109619262, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096191, encodeId=f29710961916a, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910569, encodeId=5b019105697d, content=接受meta分析吗？大神们请教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfbf1562612, createdName=zhangkaili-2009, createdTime=Thu Dec 24 10:00:35 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570172, encodeId=37565e0172e2, content=投2个多月了，还是with editor，谁知道怎磨回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL7QWEibBRUvZpBhSPzZ4XmuyiacY6Upo6KuRic0GCSNrnvAbibcQM5o0PHLyHgLqGSDkTME7IiahWGUew/132, createdBy=af0d1725742, createdName=Dennisyan, createdTime=Sun Apr 28 18:41:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893988, encodeId=11778939889b, content=什么方向易中，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b821642529, createdName=杏林阳光, createdTime=Fri Oct 23 18:58:30 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891979, encodeId=3b908919e98b, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：+维生素b, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd75425765, createdName=ms3000001625445038, createdTime=Wed Oct 14 12:18:43 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884562, encodeId=361b8845620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：分享经验：6月底投稿，1个月审回，大修，按照审稿意见补完后小修一次，9月初被接收。杂志语言要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f235196076, createdName=14728afem42暂无昵称, createdTime=Fri Sep 11 16:12:56 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578003, encodeId=20795e80035d, content=请问，接受case report<span class="quote">150****9157暂无昵称 2019-10-08 发表::<br>只有细胞实验不接收吗？</span><span class="quote">150****9157暂无昵称 2019-10-08 00:00:00 发表:<br>只有细胞实验不接收吗？</span>, beContent=150****9157暂无昵称 2019-10-08 发表:: 只有细胞实验不接收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581581, encodeId=06b658158184, content=接受临床文章不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=)]
    2020-10-23 杏林阳光

    什么方向易中，谢谢

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=577521, encodeId=11de5e75218e, content=只有细胞实验不接收吗？<span class="quote">Super Wang 2018-12-14 发表::<br>接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span><span class="quote">Super Wang 2018-12-14 00:00:00 发表:<br>挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span>, beContent=Super Wang 2018-12-14 发表:: 接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/09/c7ee18c19a20424fa380fd58a595bc4a.jpg, createdBy=5ea55077990, createdName=纯熙, createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096192, encodeId=9598109619262, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096191, encodeId=f29710961916a, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910569, encodeId=5b019105697d, content=接受meta分析吗？大神们请教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfbf1562612, createdName=zhangkaili-2009, createdTime=Thu Dec 24 10:00:35 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570172, encodeId=37565e0172e2, content=投2个多月了，还是with editor，谁知道怎磨回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL7QWEibBRUvZpBhSPzZ4XmuyiacY6Upo6KuRic0GCSNrnvAbibcQM5o0PHLyHgLqGSDkTME7IiahWGUew/132, createdBy=af0d1725742, createdName=Dennisyan, createdTime=Sun Apr 28 18:41:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893988, encodeId=11778939889b, content=什么方向易中，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b821642529, createdName=杏林阳光, createdTime=Fri Oct 23 18:58:30 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891979, encodeId=3b908919e98b, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：+维生素b, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd75425765, createdName=ms3000001625445038, createdTime=Wed Oct 14 12:18:43 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884562, encodeId=361b8845620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：分享经验：6月底投稿，1个月审回，大修，按照审稿意见补完后小修一次，9月初被接收。杂志语言要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f235196076, createdName=14728afem42暂无昵称, createdTime=Fri Sep 11 16:12:56 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578003, encodeId=20795e80035d, content=请问，接受case report<span class="quote">150****9157暂无昵称 2019-10-08 发表::<br>只有细胞实验不接收吗？</span><span class="quote">150****9157暂无昵称 2019-10-08 00:00:00 发表:<br>只有细胞实验不接收吗？</span>, beContent=150****9157暂无昵称 2019-10-08 发表:: 只有细胞实验不接收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581581, encodeId=06b658158184, content=接受临床文章不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=)]
    2020-10-14 ms3000001625445038

    审稿速度:24.0 | 投稿命中率:50.0
    经验分享：+维生素b

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=577521, encodeId=11de5e75218e, content=只有细胞实验不接收吗？<span class="quote">Super Wang 2018-12-14 发表::<br>接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span><span class="quote">Super Wang 2018-12-14 00:00:00 发表:<br>挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span>, beContent=Super Wang 2018-12-14 发表:: 接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/09/c7ee18c19a20424fa380fd58a595bc4a.jpg, createdBy=5ea55077990, createdName=纯熙, createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096192, encodeId=9598109619262, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096191, encodeId=f29710961916a, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910569, encodeId=5b019105697d, content=接受meta分析吗？大神们请教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfbf1562612, createdName=zhangkaili-2009, createdTime=Thu Dec 24 10:00:35 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570172, encodeId=37565e0172e2, content=投2个多月了，还是with editor，谁知道怎磨回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL7QWEibBRUvZpBhSPzZ4XmuyiacY6Upo6KuRic0GCSNrnvAbibcQM5o0PHLyHgLqGSDkTME7IiahWGUew/132, createdBy=af0d1725742, createdName=Dennisyan, createdTime=Sun Apr 28 18:41:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893988, encodeId=11778939889b, content=什么方向易中，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b821642529, createdName=杏林阳光, createdTime=Fri Oct 23 18:58:30 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891979, encodeId=3b908919e98b, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：+维生素b, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd75425765, createdName=ms3000001625445038, createdTime=Wed Oct 14 12:18:43 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884562, encodeId=361b8845620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：分享经验：6月底投稿，1个月审回，大修，按照审稿意见补完后小修一次，9月初被接收。杂志语言要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f235196076, createdName=14728afem42暂无昵称, createdTime=Fri Sep 11 16:12:56 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578003, encodeId=20795e80035d, content=请问，接受case report<span class="quote">150****9157暂无昵称 2019-10-08 发表::<br>只有细胞实验不接收吗？</span><span class="quote">150****9157暂无昵称 2019-10-08 00:00:00 发表:<br>只有细胞实验不接收吗？</span>, beContent=150****9157暂无昵称 2019-10-08 发表:: 只有细胞实验不接收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581581, encodeId=06b658158184, content=接受临床文章不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=)]
    2020-09-11 14728afem42暂无昵称

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：分享经验：6月底投稿，1个月审回，大修，按照审稿意见补完后小修一次，9月初被接收。杂志语言要求高。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=577521, encodeId=11de5e75218e, content=只有细胞实验不接收吗？<span class="quote">Super Wang 2018-12-14 发表::<br>接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span><span class="quote">Super Wang 2018-12-14 00:00:00 发表:<br>挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span>, beContent=Super Wang 2018-12-14 发表:: 接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/09/c7ee18c19a20424fa380fd58a595bc4a.jpg, createdBy=5ea55077990, createdName=纯熙, createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096192, encodeId=9598109619262, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096191, encodeId=f29710961916a, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910569, encodeId=5b019105697d, content=接受meta分析吗？大神们请教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfbf1562612, createdName=zhangkaili-2009, createdTime=Thu Dec 24 10:00:35 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570172, encodeId=37565e0172e2, content=投2个多月了，还是with editor，谁知道怎磨回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL7QWEibBRUvZpBhSPzZ4XmuyiacY6Upo6KuRic0GCSNrnvAbibcQM5o0PHLyHgLqGSDkTME7IiahWGUew/132, createdBy=af0d1725742, createdName=Dennisyan, createdTime=Sun Apr 28 18:41:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893988, encodeId=11778939889b, content=什么方向易中，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b821642529, createdName=杏林阳光, createdTime=Fri Oct 23 18:58:30 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891979, encodeId=3b908919e98b, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：+维生素b, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd75425765, createdName=ms3000001625445038, createdTime=Wed Oct 14 12:18:43 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884562, encodeId=361b8845620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：分享经验：6月底投稿，1个月审回，大修，按照审稿意见补完后小修一次，9月初被接收。杂志语言要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f235196076, createdName=14728afem42暂无昵称, createdTime=Fri Sep 11 16:12:56 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578003, encodeId=20795e80035d, content=请问，接受case report<span class="quote">150****9157暂无昵称 2019-10-08 发表::<br>只有细胞实验不接收吗？</span><span class="quote">150****9157暂无昵称 2019-10-08 00:00:00 发表:<br>只有细胞实验不接收吗？</span>, beContent=150****9157暂无昵称 2019-10-08 发表:: 只有细胞实验不接收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581581, encodeId=06b658158184, content=接受临床文章不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=)]
    2019-10-16 12536e50m64暂无昵称

    请问，接受case report150****9157暂无昵称 2019-10-08 发表::
    只有细胞实验不接收吗？    150****9157暂无昵称 2019-10-08 00:00:00 发表:
    只有细胞实验不接收吗？

    150****9157暂无昵称 2019-10-08 发表:: 只有细胞实验不接收吗？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=577521, encodeId=11de5e75218e, content=只有细胞实验不接收吗？<span class="quote">Super Wang 2018-12-14 发表::<br>接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span><span class="quote">Super Wang 2018-12-14 00:00:00 发表:<br>挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！</span>, beContent=Super Wang 2018-12-14 发表:: 接收率：约50% 审稿时间：约2个月 挺不错的杂志，处理很快，九月二十多号投稿，一个月就返回修改意见，十二月初接收！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/09/c7ee18c19a20424fa380fd58a595bc4a.jpg, createdBy=5ea55077990, createdName=纯熙, createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096192, encodeId=9598109619262, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096191, encodeId=f29710961916a, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910569, encodeId=5b019105697d, content=接受meta分析吗？大神们请教！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dfbf1562612, createdName=zhangkaili-2009, createdTime=Thu Dec 24 10:00:35 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570172, encodeId=37565e0172e2, content=投2个多月了，还是with editor，谁知道怎磨回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL7QWEibBRUvZpBhSPzZ4XmuyiacY6Upo6KuRic0GCSNrnvAbibcQM5o0PHLyHgLqGSDkTME7IiahWGUew/132, createdBy=af0d1725742, createdName=Dennisyan, createdTime=Sun Apr 28 18:41:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893988, encodeId=11778939889b, content=什么方向易中，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b821642529, createdName=杏林阳光, createdTime=Fri Oct 23 18:58:30 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891979, encodeId=3b908919e98b, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：+维生素b, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd75425765, createdName=ms3000001625445038, createdTime=Wed Oct 14 12:18:43 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884562, encodeId=361b8845620f, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：分享经验：6月底投稿，1个月审回，大修，按照审稿意见补完后小修一次，9月初被接收。杂志语言要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f235196076, createdName=14728afem42暂无昵称, createdTime=Fri Sep 11 16:12:56 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578003, encodeId=20795e80035d, content=请问，接受case report<span class="quote">150****9157暂无昵称 2019-10-08 发表::<br>只有细胞实验不接收吗？</span><span class="quote">150****9157暂无昵称 2019-10-08 00:00:00 发表:<br>只有细胞实验不接收吗？</span>, beContent=150****9157暂无昵称 2019-10-08 发表:: 只有细胞实验不接收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581581, encodeId=06b658158184, content=接受临床文章不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=)]
    2019-12-16 weilinjie

    接受临床文章不

    1

    展开1条回复
共232条页码: 2/24页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分